Cohort Study: Comparison of rates of Type 2 Diabetes in adults and children treated with anticonvulsant mood stabilizers.
7 Apr, 2022 | 08:32h | UTC
Commentary on Twitter
This cohort study found that the choice of which anticonvulsant mood stabilizer to initiate may have meaningful reductions in type 2 diabetes incidence; valproate was associated with the highest risk and lamotrigine the lowest. https://t.co/pyME0G25wt
— JAMA Network Open (@JAMANetworkOpen) April 6, 2022